Hypera S.A. Investor Relations Material

Hypera S.A. operates as a pharmaceutical company in Brazil. The company is involved in the production, research and development, marketing, sale and distribution of medicinal products for the treatment of various diseases such as diabetes, asthma, epilepsy and other disorders. Hypera S.A. engages through Pharmaceuticals and Biotechnologies segments. The Pharmaceuticals segment promotes and sells hyperbaric oxygen therapy (HOT) chambers to treat burns; Cortical Stimulation Therapy (CST); foot orthoses; jogging rollers; heart valves, pacemakers and implantable cardioverter defibrillator; the pregnancy test kit, pregnancy urine test kit and ovulation predictors; and iron supplements.